Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.5B | 3.4B | 4.2B | 1.4B |
| Cost of revenue | 3.1B | 3.1B | 4.0B | 1.2B |
| Gross profit | 367M | 361M | 211M | 201M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 145M | 130M | 30M | 116M |
| Other operating expenses | — | — | — | — |
| Operating income | 102M | 111M | -47M | 85M |
| Non operating interest income | ||||
| Income | — | — | — | 2M |
| Expense | 86M | 87M | — | — |
| Other income expense | 8M | 21M | 100M | -1M |
| Pretax income | 24M | 45M | -390M | 86M |
| Tax provision | 22M | 24M | -107M | 22M |
| Net income | 2M | 21M | -283M | 64M |
| Basic EPS | 0.0 | 0.1 | — | 0.4 |
| Diluted EPS | 0.0 | 0.1 | — | 0.4 |
| Basic average shares | 243M | 243M | — | 153.3M |
| Diluted average shares | 243M | 243M | — | 153.3M |
| EBITDA | 239M | 261M | 248M | 85M |
| Net income from continuing op. | 2M | 21M | -283M | 281M |
| Minority interests | 2M | -9M | 11M | -4M |
| Preferred stock dividends | — | — | — | — |